| 1 | [SID49671450] | Active | AC50 | 5.309 | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick [AID488788, Type: confirmatory] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | AC50 | 5.309 [uM] | | BioAssay | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick | | AID | 488788 | | BioAssay type | confirmatory | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 2 | [SID49671450] | Active | AC50 | 5.309 | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick [AID488788, Type: confirmatory] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | AC50 | 5.309 [uM] | | BioAssay | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick | | AID | 488788 | | BioAssay type | confirmatory | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 3 | [SID49671450] | Active | Potency | 12.5893 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 4 | [SID49671450] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 5 | [SID49671450] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID651616, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 651616 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 6 | [SID49671450] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID49671450] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts [AID652141, Type: screening] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts | | AID | 652141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID49671450] | Active | | | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme [AID2563, Type: screening] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | BioAssay | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme | | AID | 2563 | | BioAssay type | screening | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 9 | [SID49671450] | Active | | | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme [AID2563, Type: screening] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Active | | BioAssay | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme | | AID | 2563 | | BioAssay type | screening | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 10 | [SID49671450] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 11 | [SID49671450] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 12 | [SID49671450] | Inactive | Potency | 15.8489 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 13 | [SID49671450] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 14 | [SID49671450] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 15 | [SID49671450] | Inactive | Potency | 100 | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction [AID2662, Type: confirmatory] | MLL gene product [Homo sapiens] [gi:56550039] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction | | AID | 2662 | | BioAssay type | confirmatory | | Target | MLL gene product [Homo sapiens] [gi:56550039] | | PubMed | | | Data Table |  |
|
| 16 | [SID49671450] | Inactive | | | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity [AID651704, Type: screening] | MLLT3 gene product [Homo sapiens] [gi:156104889] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651704 | | BioAssay type | screening | | Target | MLLT3 gene product [Homo sapiens] [gi:156104889] | | PubMed | | | Data Table |  |
|
| 17 | [SID49671450] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 18 | [SID49671450] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 19 | [SID49671450] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 20 | [SID49671450] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 21 | [SID49671450] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 22 | [SID49671450] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 23 | [SID49671450] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 24 | [SID49671450] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 25 | [SID49671450] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 26 | [SID49671450] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 27 | [SID49671450] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 28 | [SID26535148] | Inactive | | | Cell-based luminescence-based Maybridge primary high throughput screening assay to identify agonists of NOTCH [AID434982, Type: screening] | NOTCH 1 [Homo sapiens] [gi:11275980] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26535148 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Cell-based luminescence-based Maybridge primary high throughput screening assay to identify agonists of NOTCH | | AID | 434982 | | BioAssay type | screening | | Target | NOTCH 1 [Homo sapiens] [gi:11275980] | | PubMed | | | Data Table |  |
|
| 29 | [SID49671450] | Inactive | Potency | | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 30 | [SID49671450] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 31 | [SID49671450] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 32 | [SID49671450] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 33 | [SID49671450] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 34 | [SID49671450] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 35 | [SID49671450] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 36 | [SID26535148] | Inactive | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26535148 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 37 | [SID26535148] | Inactive | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26535148 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 38 | [SID26535148] | Inactive | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26535148 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 39 | [SID26535148] | Inactive | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26535148 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 40 | [SID49671450] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 41 | [SID49671450] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 42 | [SID49671450] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 43 | [SID49671450] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 44 | [SID49671450] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 45 | [SID49671450] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 46 | [SID49671450] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 47 | [SID49671450] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 48 | [SID49671450] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 49 | [SID49671450] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 50 | [SID49671450] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49671450 | | CID | 54687868 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|